Document is current
Any future updates will be listed below
-
Authors
Nokihara, Hiroshi
Ogino, Hirokazu
Mitsuhashi, Atsushi
Kondo, Kensuke
Ogawa, Ei
Ozaki, Ryohiko
Yabuki, Yohei
Yoneda, Hiroto
Otsuka, Kenji
Nishioka, Yasuhiko
- License Information
-
More Information
Article History
Received: 26 December 2021
Accepted: 26 May 2022
First Online: 1 June 2022
Declarations
:
: This study was approved by Ethics Committee of Tokushima University. Because of its retrospective nature, the need for written informed consent was waived by the Ethics Committee of Tokushima University. All methods were carried out in accordance with Declaration of Helsinki.
: Not applicable.
: Hiroshi Nokihara has received research grant funding from AstraZeneca K.K, Chugai Pharmaceutical Co., Ltd., Nippon Pfizer Japan Inc., and speaker fees as honoraria from AstraZeneca K.K, Chugai Pharmaceutical Co., Nippon Boehringer lngelheim Co., Ltd., Eli Lilly Japan K.K., outside the submitted work. Yasuhiko Nishioka has received research grant funding from Chugai Pharmaceutical Co., Ltd., Nippon Boehringer lngelheim Co., Ltd., donation from Chugai Pharmaceutical Co., Ltd., Nippon Boehringer lngelheim Co., Ltd., Eli Lilly Japan K.K., Pfizer Japan Inc., and speaker fees as honoraria from AstraZeneca K.K, Chugai Pharmaceutical Co., Ltd., Nippon Boehringer lngelheim Co., Ltd., Pfizer Japan Inc., Eli Lilly Japan K.K. outside the submitted work. The other authors have declared no conflict of interest to disclose.
